Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Volumetric, Insulin, Syringe, Enteral, Ambulatory, Implantable Pumps), By Disease Indication, By Region, And Segment Forecasts, 2022 - 2030

Report Overview           

The global intravenous infusion pump market size was estimated at USD 5.0 billion in 2021 and is anticipated to register a CAGR of 8.2% from 2022 to 2030. Intravenous infusion pumps are used to administer medications, hormones, and nutritional fluids into the circulatory system through veins in controlled amounts. These pumps are in extensive use in clinical settings such as hospitals, nursing homes, and the home.  The pump is operated by the trained operator by programming the rate and duration of fluid delivery by means of built-in software. Intravenous infusion pumps can deliver nutrients, hormones, antibiotics, chemotherapy drugs, and pain relievers.

The advent of COVID-19 resulted in burdening of healthcare infrastructure globally as the majority of elective healthcare treatments were postponed. However, the demand for these pumps such as insulin infusion pumps and volumetric infusion pumps witnessed an increase, as the majority of the patients suffering from chronic diseases were treated remotely from home to prevent the risk of disease transmission and unburden healthcare facilities. 

Infusion pumps offer various advantages over manual administration of medicated fluids like the ability to deliver fluids in very small volumes, and the ability to deliver fluids at precisely programmed rates or automated intervals and is therefore highly adopted by healthcare systems currently. However, product recalls and infusion pumps malfunctions such as software defects and user interface issues are major growth restraining factors for the market           

Germany’s insulin infusion pumps segment is expected to grow at a high compound annual growth rate of 9.4% during the forecast period. The key factors driving the growth of the market include increased incidences of chronic diseases, rapid escalation seen in the geriatric population, rising surge for ambulatory infusion pumps, and the burgeoning number of people undergoing surgical procedures.

These pumps are mainly used to administer critical fluids that include high-risk medication. Most of the infusion pumps are equipped with safety features and inbuilt alarms for operator alerts intended to activate in the event of a problem. Many conditions such as immune deficiencies, cancer, and congestive heart failure cannot be treated with oral medications and require infusion therapy.

While administering medication, vitamins, minerals, amino acids, and varied essential micronutrients can also be added to the infusion for collateral nutrition. Smart pumps are intravenous pumps that are technologically advanced with automation, drug libraries, and various operator and patient safety features for accurate, precise, and controlled delivery of fluids into the patient system especially beneficial in the treatment of chemotherapy, and this is the reason smart pumps are gaining a lot of popularity in the medical sector.

Based on, disease indication, chemotherapy is projected to be the fastest-growing segment during the forecast period. According to the World Health Organization (WHO), 19.3 million new cases of cancer and almost 10.0 million cancer deaths were reported globally in 2020. However, effective cancer treatments are on the rise which has led to an increase in the number of cancer survivors.

Moreover, a report by the World Health Organization (WHO)predicted that the percentage of the world’s population will double from 12% to 22% between 2015- 2050 indicating the rise in the geriatric population and their high risk of experiencing chronic and long-term health conditions. This will create a market for infusion pumps that will play an important role in infusion therapies for chronically ill patients.

The demand for these pumps increased considerably after the onset of COVID-19. Smiths Medical stated that demand for items such as ventilators, airway management products, patient monitors, and infusion pumps increased substantially. The company’s revenue from infusion systems increased by 4% in 2020, driven by COVID-19-related demand. ICU medical also reported that the demand for its infusion systems increased due to high demand from existing customers and government stockpile orders.

The demand for intravenous pumps in the post-pandemic era is also expected to witness significant growth as the prevalence of diseases like diabetes, cancer, and heart ailments are expected to rise due to rapid lifestyle changes. These factors will boost market growth throughout the forecast period.

Product Insights

Volumetric infusion pumps held the largest market share of 16.8% in 2021. The high share of these pumps was due to them being capable of delivering continuous and very specific amounts of fluids at very slow to very fast rates. Based on product, the intravenous infusion pump market is segmented into volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps.

The ambulatory infusion pumps, which are used to deliver liquid nutrients and medications to a patient in both emergency situations and for chronic conditions, contributed to a significant market share in 2021, as they are widely favored for the delivery of nutrients and medications.

The availability of other pumps like patient-controlled analgesia (PCA) pumps, insulin pumps, and smart pumps will contribute to the supplementary growth of this segment. The rising demand for enteral and syringe pumps is contributing to the burgeoning preference for the Intravenous Infusion pump which will also lead to segment growth. 

Lately, smart pumps with controlled IV medication and error-prevention software are widely used as these pumps are equipped with advanced features like drug libraries, which help in storing the amount of the medicated fluid given to the patient, and its barcode technology, which helps in the verification of a patient’s identity and also helps prevent drug administration errors.

On the other hand, insulin infusion pumps are anticipated to register the highest CAGR over the forecast period.  This is due to the fact that the global burden of diabetes and related complications has surged in the last decade mainly due to changing lifestyles and urbanization. This pump segment is expected to flourish in the latter future as it has a low incidence of infections and a low incidence of delivery system failure during treatment.

Disease Indication Insights          

The pediatrics /neonatology segment held the largest market share of 26.5% in 2021. Based on disease indication, the market has been segmented into chemotherapy diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, haematology, and others. Pediatrics/Neonatology held the largest market share in 2021 owing to the fact that the treatment for pediatrics has advanced considerably and with the rising number of births globally the demand for effective pediatric care has also surged

This indicates that the segment uses intravenous infusion pumps predominantly for their medical procedures requiring the delivery of fluids at a customizable and precise programmed rate.

On the other hand, the haematology segment is estimated to advance significantly during the forecast period. With the rising incidences of surgeries and blood cancer (hemophilia), the demand for intravenous infusion pumps has seen a surge in hematology for treatments like blood transfusion, which is expected to increase in coming years.

Intravenous pumps are used for hematology as it is the only way that blood can be transfused into a patient’s body in a precise, compact, continuous manner. Moreover, the flow can be controlled manually or can be automated, avoiding the risk of failure during the treatment.

Regional Insights

The Asia Pacific market is expected to witness a significant CAGR of 8.7% during the forecast period. The regional countries are population-dense, with elevating burden of chronic diseases like diabetes, cardiovascular and cancer. These countries are also popular for their low cost of treatment and surgeries, thus being a preferred market for medical tourism.

Countries such as China, Japan, and India are emerging economies with well-developed healthcare infrastructure and facilities. Attributes like high disease burden, significant government reforms, adoption of new technology, and low cost of treatments are paving way for the market growth.

North America dominated the market in 2021 and this trend is expected to continue throughout the forecast period. Increasing Incidence of chronic diseases, an increasing number of surgical procedures performed, well-developed & increasing R&D, and escalating adoption of advanced technology in infusion pumps contributed to the growth of the market in this region.

The U.S. held the largest market share of the North America Intravenous Infusion market due to high disease prevalence, high medical R&D expenditure, and robust healthcare system. The prevalence of diabetes in the U.S. is also quite significant, which can be attributed to their lifestyle and stressed work environment. According to the Centre for Disease Control, 34.2 million population in the U.S. were diagnosed with diabetes in 2018 and the number is expected to elevate in the future.

Key Companies and Market Share Insights    

The market players are strategically utilizing drivers like shifts in technology, automation, and standardized dosing, and the extensive adoption of advanced healthcare technology for improved healthcare services. Moreover, major players often opt for geographical expansion in order to retain market share; and adopt strategies such as mergers, acquisitions, and new product launches to widen their product portfolio.

One of the key factors driving competitiveness among market players is the shift in technology, automation and standardized dosing, and the extensive adoption of advanced healthcare technology for improved healthcare services.

Moreover, major players often opt for geographical expansion in order to retain market share; and adopt strategies such as mergers, acquisitions, and new product launches to widen their product portfolio. For instance, In January 2020, Medtronic announced the launch of software Efficio to efficiently manage targeted drug delivery in SynchroMed II. Also in May 2018, Baxter International launched SpectrumIQ, an infusion pump technology with integrated EMR (Electronic Medical Records), and DeviceVue, an asset tracking software to improve the efficiency of drug delivery. Some of the prominent key players operating in the intravenous infusion pump market include:    

• Baxter International

• B. Braun Melsungen AG

• Medtronic

• Micrel Medical Devices SA

• Boston Scientific Corporation

• Becton, Dickinson, and Company

• Fresenius Kabi

• Smiths Medical

• F. Hoffmann-La Roche Ltd.

• Tandem Diabetes Care, Inc.

• Terumo Corporation

• Mindray

• Moog Inc.

• IRadimed Corporation

Intravenous Infusion Pumps Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For      this study, Grand View Research has segmented the global intravenous infusion pumps market report based on product, disease Indication, end-user and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Infusion pumps

    • Volumetric Infusion pumps

    • Insulin Infusion pumps

    •  Syringe Infusion pumps

    • Enteral Infusion pumps

    • Ambulatory Infusion pumps

    • Patient Controlled Analgesics (PCA)

    • Implantable Infusion pumps

    • Others

• Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Chemotherapy

  • Diabetes

  • Gastroenterology

  • Analgesia/Pain Management

  • Pediatrics/Neonatology

  • Hematology

  • Others

• End-User Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinics

  • Home Healthcare

  • Other End-user

•  Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

    • Netherlands

    • Belgium

    • Switzerland

    • Russia

    • Sweden

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • South Korea

    • Malaysia

    • Indonesia

    • Singapore

    • Philippines

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Israel

    • Egypt